Bibliography Updates May 2020
Myriad RBM’s biomarker testing services and TruCulture product have been cited in over 1000 peer-reviewed research articles. As a CLIA-certified labo...
Biomarker Panels Used to Predict Renal Function in Type I Diabetes
In a study published in Diabetologia1, researchers compared blood and urine-based biomarker panels to determine if they can outperform current eGFR se...
Serum Biomarker Signature Correlates With Cancer Drug Clearance and Predicts Overall Survival
In a study published in the Journal for ImmunoTherapy of Cancer December 2019 issue1, researchers demonstrate that a baseline serum biomarker signatur...
Promising Rapid, Blood Diagnosis Test for Tuberculosis Identified 1
Tuberculosis is a treatable disease that continues to kill millions of people globally. Most infected people live in regions where a timely diagno...
Tools to Profile Human Immunity
At Immunology 2019, Myriad RBM exhibited a poster, “Combining TruCulture® and OptiMAP to Profile Human Immunity." It details the immune responses (cy...
Monitoring IFN-gamma Responses in Serum
The Immunomodulatory Effects of Cancer Therapy on IFN-gamma Responses in the Periphery. (2017) Brunet LR, et al. SITC 2017 Annual Meeting; November 8...
TruCulture System Proves Superior Reproducibility Over PBMCs
Standardized whole blood stimulation system proves superior reproducibility over PBMCs A new paper on improved methods for monitoring differential im...